EX-23.1

EX-23.1 3 pstx-ex23_1.htm EX-23.1 EX-23.1

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of Poseida Therapeutics, Inc. of our report dated March 9, 2023 relating to the financial statements, which appears in Poseida Therapeutics Inc.’s Annual Report on Form 10-K for the year ended December 31, 2022.

/s/ Pricewaterhouse Coopers LLP

Irvine, California
February 8, 2024